PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco-24-02210
Authors: Michel Ducreux, Romain Desgrippes, Yves Rinaldi, Frédéric Di Fiore, Rosine Guimbaud, Ludovic Evesque, Jean-Baptiste Bachet, Pierre Vanelslander, Thierry Lecomte, Olivier Capitain, Aurélie Parzy, Marion Bolliet, Pierre-Luc Etienne, Julien Forestier, Farid El Hajbi, Anne-Laure Bignon, Valérie Lebrun-Ly, Nicolas De Sousa Carvalho, Matthieu Texier, Olivier Bouche
Institutions: Inserm, Université Paris-Saclay, Dynamique des Cellules Tumorales, Centre Hospitalier de Saint-Malo, Hôpital Européen, Hôpital Charles-Nicolle, Hôpital Rangueil, Centre Antoine Lacassagne, Sorbonne Université, Pitié-Salpêtrière Hospital, Centre Hospitalier de Saint-Quentin, Institut de Cancérologie de l'Ouest, Centre François Baclesse, Hopitaux Civils de Colmar, Hôpital Edouard Herriot, Centre Oscar Lambret, Centre Hospitalier Universitaire de Caen Normandie, Centre Hospitalier Universitaire de Limoges, UniCancer Group, Institut Gustave Roussy, Centre Hospitalier Universitaire de Reims
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410425790